.png){kind=logo}
Markets Rebound: Nifty rose above 25,100 and Sensex gained 76 points, recovering from earlier losses led by sectoral strength.
Stock-Specific Action: Biocon surged after FDA approval, Waaree Energies hit a 7-month high, and AMCs like Nippon hiked up to 74%.
Sectoral Momentum Builds: Pharma, energy, and building materials stocks gained traction, while analysts spotlighted M&M, HCL Tech, and Axis Bank as top picks.
The stock market today, on July 16, 2025, was steady as benchmark indices eliminated early losses to trade largely flat. The NSE Nifty scaled up from earlier losses to move back above the 25,100 level, up marginally by 15 points. At the same time, BSE Sensex gained 76 points to level off at 82648.33 at the time of writing.
The markets initially opened in red after the large correction earlier this week. However, they have since recovered. To that end, a few select stocks pulled well above their peers and sectoral gains offered some overall support to sentiment.
Top Gainers and Losers on Nifty 50
The Nifty 50 index witnessed good performances in various industries. M&M was leading the index with a growth of 2.07%, closing at Rs. 3,193.40. SBI came in second with a rise of 2.01% to Rs. 832.85, while Nestle rose 1.99% to hit Rs. 2,464.30.
Technology stocks offered major support. Wipro went up 1.86% to Rs. 262.20. Meanwhile, Tech Mahindra moved higher by 1.46% to Rs. 1,602.00, and Infosys went up by 1.34% to Rs. 1,606.80. Infrastructure and consumer goods segments also helped positively as Adani Ports moved higher by 1.09% and Asian Paints by 1%.
Even as the overall market recovered, a few heavyweight stocks came under selling pressure. Shriram Finance topped the losers with a fall of 2.51% to Rs. 667.25, followed by Eternal (Zomato) down 1.58% at Rs. 262.25. Pharmaceutical giant Sun Pharma lost 1.24% to Rs. 1,706.00. Steel shares JSW Steel and Tata Steel were lower by 1.02% and 0.89% respectively.
The auto space presented contrasting trends, with Tata Motors declining 0.91% to Rs. 678.20, while M&M performed well in the same segment.
Here’s a sectoral performance outlook on the stock market today:
The pharma space saw large developments that propelled stock prices upward:
Biocon Biologics was in the news as the company notified that the US Food and Drug Administration (FDA) has given Kirsty (Insulin Aspart-xjhz) 100 units/mL, a green signal. It is the first and only interchangeable biosimilar of NovoLog (Insulin Aspart). This historic approval for the subsidiary of Bengaluru-based Biocon Biologics Limited (BBL) is a milestone in the diabetes treatment market.
Waaree Energies was a top performer with the stock hitting a seven-month high of Rs. 3,341.40, up 4% on the BSE. The stock was at its highest since December 2024 after it had reached an all-time high of Rs. 3,740.75 on November 6, 2024. In the last four weeks alone, the stock has risen 25%.
Asset Management Companies Fly High
Asset Management Companies (AMCs) kept their spectacular spree going. Nippon Life India AMC (NAM-India) has led the pack, shooting a massive over 74% from a low of Rs. 492 in April to a historical high of Rs. 861.
Other AMCs also put up impressive performance, with HDFC, Aditya Birla Sun Life and UTI rising between 53-59% from their individual calendar year lows. Compared to this, BSE Sensex and NSE Nifty have risen roughly 15.5% from 2025 lows.
Building materials firms drew investor interest after they received favorable analyst coverage. Greenply Industries and Cera Sanitaryware were in the limelight after local brokerage firm Axis Securities issued a 'Buy' rating for both.
Greenply Industries stock rose by 5.49% to hit an intraday high of Rs. 320.95 per share. On the other hand, Cera Sanitaryware stock price rose 6.74% to reach an intraday high of Rs. 6,945.75.
Also Read: Ashok Leyland Share Price Tanks 50% After Bonus: No Loss to Shareholders
Oil prices increased on July 16, supported by hopes for robust summer demand in the world's two biggest consumers, the United States and China. Although gains were limited by analysts' wariness regarding the broader economy.
Purchasing the dips with a stoploss at below $3280 (MCX August gold contract Rs. 95,700) is suggested as Trump tariff issues persist. Gold can advance to the higher side of its current range, that is $3425 (Rs. 100,000), if trade tensions increase.
HDFC Bank shares are set to be in the limelight in the days leading up to the July 19 (Saturday) board meeting. The bank's board will declare the Q1 numbers and also discuss the proposal for a special dividend and its first bonus share issue at the AGM. This event is keenly awaited by market players.
As excitement gathers about the National Stock Exchange of India Ltd.'s (NSE) highly anticipated IPO. A pre-IPO run-up in its unlisted equity is nudging a valuation reality check. Even as NSE's unlisted share price has risen sharply by 283%, from Rs. 600 in 2016 to Rs. 2,200- Rs. 2,300 on July 11 this year. Analysts believe there is more steam left. Axis Securities expects an additional 74% appreciation, setting the fair value at Rs. 4,000 a share.
If you are searching for stocks to make investments in, three stocks have a good recommendation by Motilal Oswal. The list includes Mahindra & Mahindra, HCL Technologies, and Axis Bank. One of these stocks, HCL Technologies, is expected by the domestic brokerage house to yield a return of up to 23%.
Today’s stock market recovery was bolstered by solid performances from more than one sector. It was led by pharmaceuticals, energy, and asset management firms. There has been positive momentum in chosen industries, along with a solid FPI demand in some stocks. Selective stock picking and sector rotation strategies could help investors negotiate the upcoming volatility.
Also Read: Top Performing Small Cap Stocks to Check Out This Weekend
1. What is the share market position today?
On July 16, 2025, the Indian stock market demonstrated resilience by recovering from early session losses. The NSE Nifty climbed back above the 25,100 level, posting a marginal gain of around 15 points, while the BSE Sensex rose by approximately 76 points to settle at 82,648.33. Select stocks from the pharmaceutical, technology, and energy sectors helped offset the weakness.
2. Which share is best to buy today?
Among all the stocks actively traded today, Biocon Biologics emerged as a standout performer after securing FDA approval for Kirsty, its biosimilar version of Insulin Aspart. The approval is historic as it marks the first interchangeable biosimilar to NovoLog, indicating strong future earnings potential for the company.
3. Which 5 stocks to buy today?
Five promising stocks today are Biocon, Waaree Energies, Nippon Life India AMC, Greenply Industries, and Cera Sanitaryware. These stocks are rising on strong news like FDA approvals, price breakouts, or positive analyst ratings.
4. Is Indian share market open today?
Yes, the Indian share market is open today, July 16, 2025. Both major indices, the Nifty and the Sensex, have been active throughout the trading day. The Nifty rose marginally, reclaiming the 25,100 mark, and the Sensex added nearly 76 points, closing around 82,648.
5. What is the future of Biocon shares?
Biocon's stock outlook has turned positive following the U.S. FDA's approval of Kirsty (Insulin Aspart-xjhz), making it the first interchangeable biosimilar to NovoLog. This approval positions Biocon Biologics as a major global player in the insulin segment and is likely to drive strong revenue inflows in the coming quarters.
